__timestamp | AbbVie Inc. | Bristol-Myers Squibb Company |
---|---|---|
Wednesday, January 1, 2014 | 19960000000 | 15879000000 |
Thursday, January 1, 2015 | 22859000000 | 16560000000 |
Friday, January 1, 2016 | 25638000000 | 19427000000 |
Sunday, January 1, 2017 | 28216000000 | 20776000000 |
Monday, January 1, 2018 | 32753000000 | 22561000000 |
Tuesday, January 1, 2019 | 33266000000 | 26145000000 |
Wednesday, January 1, 2020 | 45804000000 | 42518000000 |
Friday, January 1, 2021 | 56197000000 | 46385000000 |
Saturday, January 1, 2022 | 58054000000 | 46159000000 |
Sunday, January 1, 2023 | 54318000000 | 45006000000 |
Monday, January 1, 2024 | 56334000000 | 48300000000 |
Unleashing insights
In the competitive landscape of the pharmaceutical industry, revenue generation is a key indicator of a company's market strength and innovation prowess. From 2014 to 2023, AbbVie Inc. and Bristol-Myers Squibb Company have been at the forefront, showcasing impressive financial growth. AbbVie Inc. has consistently outperformed its rival, with a remarkable 172% increase in revenue over the decade, peaking in 2022. In contrast, Bristol-Myers Squibb Company saw a 184% rise in revenue, with its highest earnings in 2021. Notably, AbbVie's revenue surged past Bristol-Myers in 2020, maintaining a lead with a 20% higher revenue in 2023. This trend highlights AbbVie's strategic advancements and market adaptability. As these giants continue to innovate, investors and stakeholders keenly watch their financial trajectories, anticipating future shifts in this dynamic revenue race.
Breaking Down Revenue Trends: AbbVie Inc. vs Zoetis Inc.
AbbVie Inc. vs Bristol-Myers Squibb Company: SG&A Expense Trends
AbbVie Inc. and Exelixis, Inc.: A Comprehensive Revenue Analysis
AbbVie Inc. and Alkermes plc: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Bristol-Myers Squibb Company and Viatris Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? Bristol-Myers Squibb Company or Walgreens Boots Alliance, Inc.
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Grifols, S.A.
Who Generates More Revenue? Bristol-Myers Squibb Company or Alkermes plc
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.